Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lambin

Showing results (861-870 of 939) with videos related to

Pageof 94
Sort By:
Plos One|August 13, 2013
The role of Cancer-Testis antigens as predictive and prognostic markers in non-small cell lung cancerThomas John, Maud H W Starmans, Yao-Tseng Chen, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|September 10, 2021
MRI-based delta-radiomics predicts pathologic complete response in high-grade soft-tissue sarcoma patients treated with neoadjuvant therapyJan C Peeken, Rebecca Asadpour, Katja Specht, et al.
Ecology Letters|August 24, 2017
Boom-bust dynamics in biological invasions: towards an improved application of the conceptDavid L Strayer, Carla M D'Antonio, Franz Essl, et al.
Endoscopy International Open|January 20, 2022
Endoscopic characterization of colorectal neoplasia with different published classifications: comparative study involving CONECCT classificationPaul Bonniaud, Jérémie Jacques, Thomas Lambin, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|May 23, 2024
Development and benchmarking of a Deep Learning-based MRI-guided gross tumor segmentation algorithm for Radiomics analyses in extremity soft tissue sarcomasJan C Peeken, Lucas Etzel, Tim Tomov, et al.
Molecular Therapy. Oncology|March 20, 2026
Deficiencies in the Fanconi anemia or homologous recombination pathway enhance the antitumor effects of the hypoxia-activated prodrug CP-506Lesley Schuitmaker, Alexander M A van der Wiel, Natasja G Lieuwes, et al.
JCO Precision Oncology|April 18, 2024
Tumor Size Is Not Everything: Advancing Radiomics as a Precision Medicine Biomarker in Oncology Drug Development and Clinical Care. A Report of a Multidisciplinary Workshop Coordinated by the RECIST Working GroupErica C Nakajima, Amber Simpson, Jan Bogaerts, et al.
JCO Clinical Cancer Informatics|February 8, 2019
Decision Support Systems in OncologySeán Walsh, Evelyn E C de Jong, Janna E van Timmeren, et al.
Science (New York, N.Y.)|April 6, 2013
Europe-wide dampening of population cycles in keystone herbivoresThomas Cornulier, Nigel G Yoccoz, Vincent Bretagnolle, et al.
Nuclear Medicine Communications|May 3, 2023
External validation of 18 F-FDG PET-based radiomic models on identification of residual oesophageal cancer after neoadjuvant chemoradiotherapyMaria J Valkema, Roelof J Beukinga, Avishek Chatterjee, et al.
Pageof 94

Showing results (861-870 of 939) with videos related to

Sort By:
Pageof 94
Plos One|August 13, 2013
The role of Cancer-Testis antigens as predictive and prognostic markers in non-small cell lung cancerThomas John, Maud H W Starmans, Yao-Tseng Chen, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|September 10, 2021
MRI-based delta-radiomics predicts pathologic complete response in high-grade soft-tissue sarcoma patients treated with neoadjuvant therapyJan C Peeken, Rebecca Asadpour, Katja Specht, et al.
Ecology Letters|August 24, 2017
Boom-bust dynamics in biological invasions: towards an improved application of the conceptDavid L Strayer, Carla M D'Antonio, Franz Essl, et al.
Endoscopy International Open|January 20, 2022
Endoscopic characterization of colorectal neoplasia with different published classifications: comparative study involving CONECCT classificationPaul Bonniaud, Jérémie Jacques, Thomas Lambin, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|May 23, 2024
Development and benchmarking of a Deep Learning-based MRI-guided gross tumor segmentation algorithm for Radiomics analyses in extremity soft tissue sarcomasJan C Peeken, Lucas Etzel, Tim Tomov, et al.
Molecular Therapy. Oncology|March 20, 2026
Deficiencies in the Fanconi anemia or homologous recombination pathway enhance the antitumor effects of the hypoxia-activated prodrug CP-506Lesley Schuitmaker, Alexander M A van der Wiel, Natasja G Lieuwes, et al.
JCO Precision Oncology|April 18, 2024
Tumor Size Is Not Everything: Advancing Radiomics as a Precision Medicine Biomarker in Oncology Drug Development and Clinical Care. A Report of a Multidisciplinary Workshop Coordinated by the RECIST Working GroupErica C Nakajima, Amber Simpson, Jan Bogaerts, et al.
JCO Clinical Cancer Informatics|February 8, 2019
Decision Support Systems in OncologySeán Walsh, Evelyn E C de Jong, Janna E van Timmeren, et al.
Science (New York, N.Y.)|April 6, 2013
Europe-wide dampening of population cycles in keystone herbivoresThomas Cornulier, Nigel G Yoccoz, Vincent Bretagnolle, et al.
Nuclear Medicine Communications|May 3, 2023
External validation of 18 F-FDG PET-based radiomic models on identification of residual oesophageal cancer after neoadjuvant chemoradiotherapyMaria J Valkema, Roelof J Beukinga, Avishek Chatterjee, et al.
Pageof 94